Advance Search
WANG Ying, LI An'na. Effect observation of clopidogrel combined with aspirin in the treatment of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 73-76. DOI: 10.7619/jcmp.202012021
Citation: WANG Ying, LI An'na. Effect observation of clopidogrel combined with aspirin in the treatment of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 73-76. DOI: 10.7619/jcmp.202012021
shu

Effect observation of clopidogrel combined with aspirin in the treatment of patients with coronary heart disease

  • Cardiothoracic Department, Shaanxi Provincial Armed Police Corps Hospital, Xi'an, Shaanxi, 710000

More Information
  • Received Date: April 05, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the effect of clopidogrel combined with aspirin in the treatment of patients with coronary heart disease. Methods Totally 360 patients with coronary heart disease were randomly divided into treatment group and control group. The control group was treated with aspirin, and the treatment group was treated with clopidogrel on the basis of the control group. The therapeutic effect, coagulation indexes and adverse reactions were compared between the two groups. Results The total effective rate of the treatment group was 95.56%, which was significantly higher than 87.78% of the control group(P<0.05). After treatment, there were no significant differences in plasma prothrombin time and prothrombin activity between the two groups(P>0.05), but the activated partial thromboplastin time in the treatment group was significantly longer than that in the control group(P<0.05). After treatment, the left ventricular end diastolic diameter of the treatment group was significantly smaller than that of the control group(P<0.05), and the left ventricular ejection fraction was significantly higher than that of the control group(P<0.05). After treatment, the incidence of adverse reactions in the treatment group was 4.44%, which was significantly lower than 11.11% in the control group(P<0.05). Conclusion Clopidogrel combined with aspirin is safe and effective in the treatment of patients with coronary heart disease, which can significantly alleviate the clinical symptoms and promote the recovery of patients.
    • FullText(HTML)
    • References (18)
  • 高文俊. 丹参多酚酸盐联合氯吡格雷治疗冠心病的疗效及对血脂、血管内皮功能、血小板的影响[J]. 中西医结合心脑血管病杂志, 2018, 16(6): 745-748.
    袁玉亮, 王娜. 丹参多酚酸盐治疗冠心病的效果及对患者免疫炎症反应的影响[J]. 国际免疫学杂志, 2018, 41(2): 238-242.
    王立羽, 白丽虹, 王爽. 硫酸氢氯吡格雷联合阿司匹林肠溶片治疗脑梗死的疗效及对血清高敏C反应蛋白、血脂、颈总动脉内膜中层厚度的影响[J]. 广西医学, 2017, 39(4): 481-483.
    姚芸. 阿司匹林联合氯吡格雷治疗老年冠心病心绞痛的疗效分析[J]. 中西医结合心血管病电子杂志, 2017, 5(32): 13-14.
    王阳, 王镇波. 阿司匹林肠溶片联合硫酸氢氯吡格雷片治疗冠心病心绞痛的效果分析[J]. 中国急救医学, 2018, 38(z2): 29-32.
    路雪梅. 硫酸氢氯吡格雷联合阿司匹林治疗老年冠心病对凝血指标、血小板聚集率的影响分析[J]. 中西医结合心血管病电子杂志, 2018, 16(14): 22-23.
    欧番文, 滕璇, 梁牧. 氯吡格雷联合阿司匹林治疗冠心病患者经皮冠状动脉介入治疗术后抗血小板疗效影响[J]. 吉林医学, 2016, 37(11): 2744-2746.
    杨炫露, 温静雅. 波利维和阿司匹林治疗冠心病的临床探讨[J]. 医药论坛杂志, 2017, 38(12): 157-158.
    郑彬彬, 林芳, 高瞻. 心理干预联合阿司匹林及替格瑞洛在急性心肌梗死患者中手术治疗中的应用及对生活质量的影响研究[J]. 中国生化药物杂志, 2017, 42(7): 319-320.
    陈进涛. 替格瑞洛联合阿司匹林对急性心肌梗死冠脉介入患者预后的影响[J]. 西藏医药, 2019, 45(3): 74-75.
    刘芳. 评价替格瑞洛片联合阿司匹林治疗急性心肌梗死的临床疗效及安全性[J]. 中西医结合心血管病电子杂志, 2018, 6(10): 82-83.
    李丕武, 王海燕, 张斌, 等. 阿司匹林联合氯吡格雷对大脑中动脉狭窄致脑梗死稳定期患者相关指标的影响[J]. 中国药房, 2017, 28(30): 4209-4212.
    吴水珍. 氯吡格雷联合阿司匹林治疗老年人冠心病的临床疗效及对凝血指标、血小板聚集率的影响[J]. 中国基层医药, 2014, 21(16): 2537-2538.
    卢丽华, 潘朝庆, 李学林, 等. 双联抗血小板治疗对冠心病患者凝血纤溶指标及血小板功能的影响[J]. 血栓与止血学, 2018, 24(2): 263-265.
    安健, 魏首栋, 雷新宇, 等. 高龄患者复杂经皮冠状动脉介入术后应用加倍剂量氯吡格雷的疗效观察[J]. 中国药物与临床, 2019, 19(6): 933-935.
    边妍, 潘芸芸, 陈吉生. 硫酸氢氯吡格雷片仿制药对比原研药治疗冠心病的疗效、安全性与经济性的系统评价[J]. 中国药房, 2018, 29(21): 106-110.
    蔡雷. 小剂量阿司匹林治疗老年冠心病患者的远期疗效观察[J]. 血栓与止血学, 2017, 24(23): 1001-1003.
    张月超. 硫酸氢氯吡格雷片联合阿托伐他汀钙对冠心病PCI术后心绞痛患者血清血脂水平、sCD40L及sICAM-1水平的影响[J]. 标记免疫分析与临床, 2019, 26(7): 1200-1203

    , 1227.
    • Related Articles

  • Related Articles

    [1]YU Fulin, HUANG Jiangbo, NING Yangshan. Correlations of serum phosphoglycerate mutase family member 5 and YT521-B homology N6-methyladenosine RNA binding protein 2 levels with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 64-69. DOI: 10.7619/jcmp.20244630
    [2]HE Lan, LU Yang, XIA Zhigang, XIE Xiaoyi, DU Lili, GU Shulian, MA Lan, HE Yongming, SHEN E. A preliminary exploration of a deep learning-based artificial intelligence model for automatic quantification of echocardiographic left ventricular ejection fraction[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 9-14. DOI: 10.7619/jcmp.20240289
    [3]LIU Rongzhi, LIN Zixiang, CHEN Haijin, QIU Xiaoyan, HE Jianjun, WAN Yu, WEN Shengxin, CHEN Shaoyuan. Effect observation of dagliazine in treatment of patients with heart failure with reduced ejection fraction[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 35-39, 45. DOI: 10.7619/jcmp.20223187
    [4]DAI Yonghui, CHEN Yong. Effect of hyperdynamic left ventricular ejection fraction on prognosis of early septic shock patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 76-80. DOI: 10.7619/jcmp.20222995
    [5]WEN Lu, OUYANG Hui, YUAN Hao, TIAN Jing, ZHANG Fang. Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 46-50. DOI: 10.7619/jcmp.20222662
    [6]YAO Dan, ZHENG Ju, PANG Chong, WU Yanming, YOU Hua. Effect of sacubitril/valsartan on echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 81-84, 88. DOI: 10.7619/jcmp.20210125
    [7]SHI Gang, ZHU Lin, ZHANG Yuhong, ZHAO Yong. Effect of Ginkgo Leaf Extract and Dipyridamole Injection on left ventricular ejection fraction and serum B-type natriuretic peptide in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 44-46. DOI: 10.7619/jcmp.202018012
    [8]ZHANG Liwei. Correlations between serum uric acid, N-terminal pro-B-type natriuretic peptide, vasostatin-2 and left ventricular ejection fraction in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 29-31. DOI: 10.7619/jcmp.202012008
    [9]CHEN Gang. Correlation between resting heart rate and serum high sensitive C reactive protein, brain natriuretic peptide and left ventricular ejection fraction in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 31-33, 36. DOI: 10.7619/jcmp.201924010
    [10]QU Linnan, CUI Yufang, YU Bin. Effect of early rehabilitation on left ventricular ejection fraction and exercise tolerance in patients with acute myocardial infarction treated by radial artery PCI[J]. Journal of Clinical Medicine in Practice, 2017, (8): 5-7. DOI: 10.7619/jcmp.201708002

Catalog

    Get Citation
    PDF
    XML
    Article views (355) PDF downloads (14) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return